Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-02-07T07:46:29.279Z Has data issue: false hasContentIssue false
  • English
  • Français

Innovative Law and Policy Responses to the Opioid Crisis

Published online by Cambridge University Press:  01 January 2021

James G. Hodge Jr. ,
Chelsea L. Gulinson ,
Leila Barraza ,
Haley R. Augur ,
Michelle Castagne ,
Ashley Cheff ,
Drew Hensley ,
Madeline Sobek  and
Adina Weisberg
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Public Health and the Law
Information
Journal of Law, Medicine & Ethics , Volume 47 , Issue 1: Sharing Data in a Medical Information Commons , Spring 2019 , pp. 173 - 176
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Joynt, M. et al., “The Impact of Neighborhood Socioeconomic Status and Race on the Prescribing of Opioids in Emergency Departments Throughout the United States,” Journal of General Internal Medicine 28, no. 12 (2013): 1604-1610.CrossRefGoogle Scholar
Centers for Disease Control and Prevention, Drug Overdose Deaths in the United States, 1999-2016, available at <https://www.cdc.gov/nchs/products/databriefs/db294.htm> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Centers for Disease Control and Prevention, Provisional Drug Overdose Death Counts, available at <https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
European Monitoring Centre for Drugs and Drug Addiction, “Drug Consumption Rooms: An Overview of Provision and Evidence,” June 7, 2018, available at <http://www.emcdda.europa.eu/topics/pods/drug-consumption-rooms> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Kral, A.H. and Davidson, P.J., “Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S.,” American Journal of Preventive Medicine 53, no. 6 (2017): 919-922.CrossRefGoogle Scholar
United States v. Safehouse, civil action no. 19-cv-519, February 5, 2019.Google Scholar
Centers for Disease Control and Prevention, Prescription Opioid Data, available at <https://www.cdc.gov/drugoverdose/data/prescribing.html> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Dowell, D. et al., “CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016,” March 18, 2016, available at <https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm> (last visited February 12, 2019).CrossRef+(last+visited+February+12,+2019).>Google Scholar
Shah, A. et al., “Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015,” March 17, 2017, available at <https://www.cdc.gov/mmwr/volumes/66/wr/mm6610a1.htm> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
National Council of State Legislators, Prescribing Policies: States Confront Opioid Overdose Epidemic, October 31, 2018, available at <http://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Farmer, B., “Insurer To Purdue Pharma: We Won't Pay For OxyContin Anymore,” National Public Radio, September 12, 2018, available at <https://www.npr.org/sections/health-shots/2018/09/12/646790014/insurers-move-against-oxycontin> (last visited February 12, 2018).Google Scholar
Food and Drug Administration, “FDA Acts to Protect Kids from Serious Risks of Opioid Ingredients Contained in Some Prescription Cough and Cold Products by Revising Labeling to Limit Pediatric Use,” January 11, 2018, available at <https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592109.htm> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
California Dental Association, “ADAD Advances National Policy to Reduce Opioid Dependency,” March 28, 2018, available at <https://www.cda.org/news-events/ada-advances-national-policy-to-reduce-opioid-dependency> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
American Dental Association, “American Dental Association Announces New Policy to Combat Opioid Epidemic,” March 26, 2018, available at <https://www.ada.org/en/press-room/news-releases/2018-archives/march/american-dental-association-announces-new-policy-to-combat-opioid-epidemic> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Gostin, L.O. et al., “Reframing the Opioid Epidemic as a National Emergency,” Journal of the American Medical Association 318, no. 16 (2017): 1539-1540.CrossRefGoogle Scholar
Food and Drug Administration, “Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Efforts to Advance New Ways to Increase the Availability of Naloxone as One Means for Reducing Opioid Overdose Deaths,” October 23, 2018, available at <https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624053.htm> (last visited February 13, 2019). (last visited February 13, 2019).' href=https://scholar.google.com/scholar?q=Food+and+Drug+Administration,+“Statement+from+FDA+Commissioner+Scott+Gottlieb,+M.D.,+on+Agency's+Efforts+to+Advance+New+Ways+to+Increase+the+Availability+of+Naloxone+as+One+Means+for+Reducing+Opioid+Overdose+Deaths,”+October+23,+2018,+available+at++(last+visited+February+13,+2019).>Google Scholar
Bebinger, M., “VA Adding Opioid Antidote to Defibrillator Cabinets for Quicker Overdose Response,” National Public Radio, September 27, 2018, available at <https://www.npr.org/sections/health-shots/2018/09/27/650639122/va-adding-opioid-antidote-to-defibrillator-cabinets-for-quicker-overdose-response> (last visited February 12, 2019).Google Scholar
Hoffman, J., “Opioid Lawsuits Are Headed to Trial. Here's Why the Stakes Are Getting Uglier,” New York Times, January 30, 2019, available at <https://www.nytimes.com/2019/01/30/health/opioid-lawsuits-settlement-trial.html> (last visited February 12, 2019). (last visited February 12, 2019).' href=https://scholar.google.com/scholar?q=Hoffman,+J.,+“Opioid+Lawsuits+Are+Headed+to+Trial.+Here's+Why+the+Stakes+Are+Getting+Uglier,”+New+York+Times,+January+30,+2019,+available+at++(last+visited+February+12,+2019).>Google Scholar
Complaint, The Navajo Nation v. Purdue Pharma, et. al., No. 1:17-MD-02804-DAP (N.D. Ohio Jan. 23, 2019), MDL No. 2804.Google Scholar
Ward, B., “West Virginia Cities Sue Joint Commission Over Alleged Role in Opioid Crisis,” HCPro Blog, November 9, 2017, available at <http://blogs.hcpro.com/acc/2017/11/west-virginia-cities-sue-joint-commission-over-alleged-role-in-opioid-crisis/> (last visited February 12, 2019).Google Scholar
Mattise, J., “Feds Halt 2 Tennessee Pharmacies' Opioid Dispensing for Now,” Washington Post, February 8, 2019, available at <https://www.washingtonpost.com/national/health-science/feds-halt-2-tennessee-pharmacies-opioid-dispensing-fornow/2019/02/08/71f3e8f8-2c01-11e9-906e-9d55b6451eb4_story.html?utm_term=.40ac2ee1f9a7> (last visited February 12, 2019). (last visited February 12, 2019).' href=https://scholar.google.com/scholar?q=Mattise,+J.,+“Feds+Halt+2+Tennessee+Pharmacies'+Opioid+Dispensing+for+Now,”+Washington+Post,+February+8,+2019,+available+at++(last+visited+February+12,+2019).>Google Scholar
Associated Press, “US Border Agency Says It's Made Biggest-Ever Fentanyl Bust,” New York Times, January 31, 2019, available at <https://www.nytimes.com/aponline/2019/01/31/us/ap-us-fentanyl-seizure.html> (last visited February 12, 2019). (last visited February 12, 2019).' href=https://scholar.google.com/scholar?q=Associated+Press,+“US+Border+Agency+Says+It's+Made+Biggest-Ever+Fentanyl+Bust,”+New+York+Times,+January+31,+2019,+available+at++(last+visited+February+12,+2019).>Google Scholar
Rockwell, M., “Opening Bids on DHS Funding Include More Border Tech,” Business of Federal Technology, January 31, 2019, available at <https://fcw.com/articles/2019/01/31/border-tech-congress-rockwell.aspx> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
H.R. 6, 115th Cong. (2018).Google Scholar
Centers for Disease Control and Prevention, “Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas — United States,” October 20, 2017, available at <http://dx.doi.org/10.15585/mmwr.ss6619a1> (last visited February 12, 2019).CrossRef+(last+visited+February+12,+2019).>Google Scholar
Andrilla, CHA et al., “Changes in the Supply of Physicians with a DEA DATA Waiver to Prescribe Buprenorphine for Opioid Use Disorder,” Rural Health Research & Policy Centers, May 2017, available at <http://depts.washington.edu/fammed/rhrc/wp-content/uploads/sites/4/2017/05/RHRC_DB162_Andrilla.pdf> (last visited February 12, 2019).Google Scholar
42 U.S.C. § 1315 (2019).Google Scholar
Legal Services Corporation, “How Legal Aid Addresses the Opioid Crisis,” available at <https://www.lsc.gov/media-center/publications/how-legal-aid-addresses-opioid-crisis> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar
Levi, J.G. et al., “Meeting the Challenge of the Legal Aid Crisis,” National Law Journal, May 4, 2018, available at <https://www.law.com/nationallawjournal/2018/05/04/meeting-the-challenge-of-the-legal-aid-crisis/> (last visited February 12, 2019).+(last+visited+February+12,+2019).>Google Scholar